Predictive value of APOE genotyping in incipient Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 58-69

  Petersen, Ronald C ^a   Waring, Stephen C ^a   Smith, Glenn E ^a   Tangalos, Eric G ^a   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; AMNESIA; COGNITIVE DEFECT; COMMUNITY; CONFERENCE PAPER; DIAGNOSTIC VALUE; FOLLOW UP; GENOTYPE; HETEROZYGOSITY; HUMAN; LONGITUDINAL STUDY; ONSET AGE; PREDICTION; RISK FACTOR;

BIKINIA LE-TESTUI;

EID: 0030450730     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32599.x     Document Type: Conference Paper

References (42)

1. MAYEUX, R., Y. STERN, R. OTTMAN, T. K. TATEMICHI, M-X TANG, G. MAESTRE, C. NGAI, B. TYCKO & H. GINSBERG. 1993. The apolipoprotein e4 allele in patients with Alzheimer's disease. Ann. Neurol. 34: 752-754.
2. COUDERC, R., F. MAHIEUX & S. BAILLEUL. 1993. Apolipoprotein e4 allele frequency ischemic cerebrovascular disease, and Alzheimer's disease. Stroke 24: 1416-1417.
3. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST. GEORGE-HYSLOP, M. A. PERICAK-VANCE, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACHLAN, M. J. ALBERTS, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
4. CHARTIER-HARLIN, M. C., M. PARFITT, S. LEGRAIN, J. PEREZ-TUR, T. BROUSSEAU, A. EVANS, C. BERR, O. VIDAL, P. ROQUES, V. GOURLET, et al. 1994. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3: 569-574.
5. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
6. AMOUYEL, P., O. VIDAL, J. M. LAUNAY & J. L. LAPLANCHE. 1994. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 344: 1315-1318.
7. LIPPA, C. F., T. W. SMITH, A. M. SAUNDERS, R. CROOK, D. PULASKI-SALO, P. DAVIES, J. HARDY, A. D. ROSES & D. DICKSON. 1995. Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97-103.
8. DAVIGNON, J., R. E. GREGG & C. F. SING. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21.
9. HYMAN, B. T., H. L. WEST, G. W. REBECK, F. LAI & D. M. MANN. 1995. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch. Neurol. 52: 373-378.
10. KOLLER, W. C., S. L. GLATT, J. P. HUBBLE, A. PAOLO, A. I. TROSTER, M. S. HANDLER, R. T. HORVAT, C. MARTIN, K. SCHMIDT, A. KARST, E. M. WIJSMAN, C-E YU & G. D. SCHELLENBERG. 1995. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann. Neurol. 37: 242-245.
11. KAWAMATA, J., S. TANAKA, S. SHIMOHAMA, K. UEDA & J. KIMURA. 1994. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry 57: 1414-1416.
12. MUI, S., G. W. REBECK, D. MCKENNA-YASEK, B. T. HYMAN & R. H. BROWN. 1995. Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann. Neurol. 38: 460-463.
13. TABATON, M., M. ROLLERI, P. MASTURZO, S. CAMMARATA, G. ANGELINI, L. A. HANSEN, T. SAITOH, R. B. PETERSEN, G. PERRY, P. RICHEY, P. GAMBETTI & S. BERTOLINI. 1995. Apolipoprotein E ε4 allele frequency is not increased in progressive supranuclear palsy. Neurology 45: 1764-1765.
14. WARING, S. C., P. C. O'BRIEN, L. T. KURLAND, S. N. THIBODEAU, M-S TSAI, R. C. PETERSEN & C. E. ESTEBAN-SANTILLAN. 1994. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet 343: 611.
15. ROSES, A. D. 1995. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38: 6-14.
16. BIRD, T. D. 1995. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view. Ann. Neurol. 38: 2-4.
17. AMERICAN COLLEGE OF MEDICAL GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS WORKING GROUP ON APOE AND ALZHEIMER DISEASE. 1995. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA 274: 1627-1629.
18. GANDY, S. & N. RELKIN. 1995. Guidelines for ApoE genotyping in Alzheimer's. Neurol. Alert 14: 9-11.
19. PETERSEN, R. C. 1995. Normal aging, mild cognitive impairment, and early Alzheimer's disease. The Neurologist 1: 326-344.
20. STRITTMATTER, W. J., A. M. SAUNDERS, D. SCHMECHEL, M. PERICAK-VANCE, J. ENGHILD, G. S. SALVESEN & A. D. ROSES. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
21. DAI, X. Y., S. NANKO, M. HATTORI, R. FUKUDA, K. NAGATA, K. ISSE, A. UEKI & H. KAZAMATSURI. 1994. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci. Lett. 175: 74-76.
22. TSAI, M-S., E. G. TANGALOS, R. C. PETERSEN, G. E. SMITH, D. J. SCHAID, E. KOKMEN, R. J. IVNIK & S. N. THIBODEAU. 1994. Apolipoprotein E: Risk factor for Alzheimer's disease. Am. J. Hum. Genet. 54: 643-649.
23. JARVIK, G. P., E. M. WIJSMAN, W. A. KUKULL, G. D. SCHELLENBERG, C. YU & E. B. LARSON. 1995. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study. Neurology 45: 1092-1096.
24. POIRIER, J., J. DAVIGNON, D. BOUTHILLIER, S. KOGAN, P. BERTRAND & S. GAUTHIER. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
25. VAN DUIJN, C. M., P. DE KNIJFF, M. CRUTS, A. WEHNERT, L. M. HAVEKES, A. HOFMAN & C. VAN BROECKHOVEN. 1994. Apolipoprotein e4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7: 74-78.
26. PETERSEN, R. C., E. KOKMEN, E. G. TANGALOS, R. J. IVNIK & L. T. KURLAND. 1990. Mayo Clinic Alzheimer's Disease Patient Registry. Aging 2: 408-415.
27. PETERSEN, R. C., G. E. SMITH, R. J. IVNIK, E. KOKMEN & E. G. TANGALOS. 1994. Memory function in very early Alzheimer's disease. Neurology 44: 867-872.
28. IVNIK, R. J., J. F. MALEC, G. E. SMITH, E. G. TANGALOS, R. C. PETERSEN, E. KOKMEN & L. T. KURLAND. 1992. Mayo's older Americans normative studies: WAIS-R norms for ages 56 to 97. The Clinical Neuropsychologist 6(Suppl): 1-30.
29. PETERSEN, R. C., G. E. SMITH, E. KOKMEN, R. J. IVNIK & E. G. TANGALOS. 1992. Memory function in normal aging. Neurology 42: 396-401.
30. PETERSEN, R. C., G. E. SMITH, R. J. IVNIK, E. G. TANGALOS, D. J. SCHAID, S. N. THIBODEAU, E. KOKMEN, S. C. WARING & L. T. KURLAND. 1995. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA 273: 1274-1278.
31. AMERICAN PSYCHIATRIC ASSOCIATION. 1987. Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. American Psychiatric Association. Washington, DC.
32. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STADLAN. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
33. HUGHES, C. P., L. BERG, W. L. DANZIER, L. A. COBEN & R. L. MARTIN. 1982. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140: 566-572.
34. BERG, L. 1988. Clinical Dementia Rating (CDR). Psychopharmacol. Bull. 24: 637-639.
35. MORRIS, J. C. 1993. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43: 2412-2414.
36. CHUI, H. C., J. I. VICTOROFF, D. MARGOLIN, W. JAGUST, R. SHANKLE & R. KATZMAN. 1992. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42(3): 473-480.
37. ROMAN, G. C., T. K. TATEMICHI, T. ERKINJUNTTI, J. L. CUMMINGS, J. C. MASDEU, J. H. GARCIA, L. AMADUCCI, J. M. ORGOGOZO, A. BRUN, A. HOFMAN, et al. 1993. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-260.
38. REISBERG, B., S. H. FERRIS, M. J. DE LEON & T. CROOK. 1982. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139: 1136-1139.
39. BENTON, A. L., K. HAMSHER, N. R. VARNEY & O. SPREEN. 1983. Contributions to Neuropsychological Assessment. Oxford University Press. New York.
40. BENTON, A. L. & K. HAMSHER. 1978. Multilingual Aphasia Examination (manual). University of Iowa. Iowa City, IA.
41. LEZAK, M. D. 1995. Neuropsychological Assessment. 3rd edition. Oxford University Press. New York.
42. WARING, S. C., W. A. ROCCA, D. J. SCHAID, R. C. PETERSEN, E. G. TANGALOS, S. N. THIBODEAU & E. KOKMEN. 1995. Apolipoprotein E and Alzheimer's disease: Trends in risk by age at onset. Ann. Neurol. 38(2): 324.